A new protecting group for aspartic acid that minimizes piperidine-catalyzed aspartimide formation in fmoc solid phase peptide synthesis

DOI: 10.1016/0040-4039(96)00807-6

Source and publish data:

Tetrahedron Letters p. 4243 - 4246 (1996)

Update date:2022-08-03

Topics:

Authors:

Karlstroem, Amelie

Unden, Anders

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1016/0040-4039(96)00807-6

The β-3-methylpent-3-yl ester of Fmoc aspartic acid, Fmoc-Asp(OMpe)-OH, is presented as a new protecting group for aspartic acid which provides good protection against base-catalyzed aspartimide formation in Fmoc solid phase peptide synthesis. Copyright

Full text of DOI:10.1016/0040-4039(96)00807-6

Products guided by the article

Product name:Butanoic acid, 4-chloro-2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-4-oxo-, phenylmethyl ester, (S)-

Cas No:180675-09-6

R&D Labs maybe for 180675-09-6

Ningbo Huajia Chemicals

Contact:+86-574-87065746

Address:10th Floor, No.787 Baizhang East Road,
Shanghai Puda Chemical Co.,Ltd

Contact:+86+571+56565965

Address:10F Haiyue Building,Danfeng Road,Binjiang District,Hangzhou,China
Laohekou Jinghong Chemical Co.,Ltd

Contact:+86-0710-3702747

Address:163.East，Huagong Road，Laohekou
Advanced Biotech

Contact:+1-973-357-0577

Address:10 Taft Rd.
Xi'an Yuri Solar Co., Ltd

website:https://www.yurisolar.com/en

Contact:86--18092602675

Address:No. 560, East Hangtian Road, Xi'an, China

Relevant to this article

Semi-synthesis and NMR spectral assignments of flavonoid and chalcone derivatives

Doi:10.1002/mrc.4482
(2016)
5-(5,6-Dichloro-2-indolyl)-2-methoxy-2,4-pentadienamides: Novel and selective inhibitors of the vacuolar H⁺-ATPase of osteoclasts with bone antiresorptive activity

Doi:10.1021/jm9800144
(1998)
Palladium-catalyzed stereoselective synthesis of (E,E)-1-arylselenobutadienes

Doi:10.1055/s-1996-4362
(1996)
Mechanically induced solvent-free esterification method at room temperature

Doi:10.1039/d0ra09437d
(2021)
Dual-targeting liposome modified by glutamic hexapeptide and folic acid for bone metastatic breast cancer

Doi:10.1016/j.chemphyslip.2020.104882
(2020)
Doi:10.1016/0040-4020(68)89024-6
(1968)

Article Doi